University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Methotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysis

dc.contributor.authorSolangon, Sarah Annie
dc.contributor.authorVan Wely, Madelon
dc.contributor.authorVan Mello, Norah
dc.contributor.authorMol, Ben W
dc.contributor.authorRoss, Jackie A
dc.contributor.authorJurkovic, Davor
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.date.accessioned2023-07-24T13:42:01Z
dc.date.available2023-07-24T13:42:01Z
dc.date.issued2023-09
dc.descriptionFunding Information: The NL study ran between April 2007 and January 2012 and included 73 women with conclusive ultrasound diagnosis of tubal EP with hCG <1500 IU/L or suspected tubal EP (PUL with plateauing serum hCG) <2000 IU/L. This was funded by a grant of the Netherlands Organization for Health Research and Development (ZonMw Clinical fellow grant 90700154). The UK study ran between August 2005 and June 2014 and included 80 women with conclusive ultrasound diagnosis of tubal EP and a serum hCG <1500 IU/L. This did not receive external funding. Baseline characteristics of intervention and comparison groups were similar and all prespecified outcomes were reported in both studies. Further characteristics of both studies are outlined in Table 1 . 9 11en
dc.description.statusPeer revieweden
dc.format.extent17
dc.format.extent2575715
dc.identifier267590582
dc.identifierccb881e6-2383-4000-bb9c-761287f2d59c
dc.identifier37345445
dc.identifier85163202348
dc.identifier.citationSolangon, S A, Van Wely, M, Van Mello, N, Mol, B W, Ross, J A & Jurkovic, D 2023, 'Methotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysis', Acta Obstetricia et Gynecologica Scandinavica, vol. 102, no. 9, pp. 1159-1175. https://doi.org/10.1111/aogs.14617en
dc.identifier.doi10.1111/aogs.14617
dc.identifier.iss9en
dc.identifier.issn0001-6349
dc.identifier.otherunpaywall: 10.1111/aogs.14617
dc.identifier.urihttps://hdl.handle.net/2164/21290
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85163202348&partnerID=8YFLogxKen
dc.identifier.vol102en
dc.language.isoeng
dc.relation.ispartofActa Obstetricia et Gynecologica Scandinavicaen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectexpectant managementen
dc.subjectmedical treatmenten
dc.subjectmethotrexateen
dc.subjectpregnancy ectopicen
dc.subjectpregnancy tubalen
dc.subjectPregnancy, Ectopic/drug therapyen
dc.subjectHumansen
dc.subjectPregnancy, Tubal/drug therapyen
dc.subjectChorionic Gonadotropinen
dc.subjectPregnancyen
dc.subjectFemaleen
dc.subjectWatchful Waitingen
dc.subjectRetrospective Studiesen
dc.subjectAbortifacient Agents, Nonsteroidal/therapeutic useen
dc.subjectMethotrexate/therapeutic useen
dc.subjectRG Gynecology and obstetricsen
dc.subjectObstetrics and Gynaecologyen
dc.subject.lccRGen
dc.titleMethotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysisen
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Solangon_Etal_AOGS_Methotrexate_Versus_Expectant_VOR.pdf
Size:
2.46 MB
Format:
Adobe Portable Document Format

Collections